Supplementary Figure S3 from Camizestrant in Combination with Three Globally Approved CDK4/6 Inhibitors in Women with ER+, HER2− Advanced Breast Cancer: Results from SERENA-1

Authors

Bairu Zhang (ORCID: https://orcid.org/0000-0002-2753-9407)
Erika Hamilton (ORCID: https://orcid.org/0000-0002-1911-0336)
Manish R. Patel (ORCID: https://orcid.org/0000-0001-6836-2364)
Begoña Bermejo (ORCID: https://orcid.org/0000-0001-7773-5994)
Iván Victoria (ORCID: https://orcid.org/0000-0002-8733-6089)
Peter Kabos (ORCID: https://orcid.org/0000-0003-1500-471X)
Chris Twelves (ORCID: https://orcid.org/0000-0002-1849-7153)
Andy Sykes (ORCID: https://orcid.org/0000-0003-2257-4841)
Alastair Mathewson
Mafalda Oliveira (ORCID: https://orcid.org/0000-0001-9152-8799)
Anne Caroline Armstrong (ORCID: https://orcid.org/0000-0002-0774-7006)
Carmela Ciardullo (ORCID: https://orcid.org/0000-0002-0809-2136)
Teresa Klinowska (ORCID: https://orcid.org/0000-0003-1997-7340)
Nicholas C. Turner (ORCID: https://orcid.org/0000-0001-8937-0873)
Christos Vaklavas (ORCID: https://orcid.org/0000-0002-9919-2748)
Christopher J. Morrow (ORCID: https://orcid.org/0000-0003-1524-9426)
Manuel Ruíz-Borrego (ORCID: https://orcid.org/0000-0002-1181-5622)
Irene Moreno (ORCID: https://orcid.org/0000-0001-5027-6388)
Justin P.O. Lindemann (ORCID: https://orcid.org/0000-0003-1531-9754)
Jason Incorvati
Eva Ciruelos (ORCID: https://orcid.org/0000-0002-2796-1042)
Richard D. Baird (ORCID: https://orcid.org/0000-0001-7071-6483)
Jincheng Yang (ORCID: https://orcid.org/0000-0002-4813-1056)

Publication Details

Published: 2025-10-15
DOI: https://doi.org/10.1158/1078-0432.30363339
Primary Topic: Advanced Breast Cancer Therapies
Type: article
Field-Weighted Citation Impact: 0.00

Supplementary Figure S3 from Camizestrant in Combination with Three Globally Approved CDK4/6 Inhibitors in Women with ER+, HER2− Advanced Breast Cancer: Results from SERENA-1

Bairu Zhang, Erika Hamilton, Manish R. Patel, Begoña Bermejo, Iván Victoria, Peter Kabos, Chris Twelves, Andy Sykes, Alastair Mathewson, Mafalda Oliveira, Anne Caroline Armstrong, Carmela Ciardullo, Teresa Klinowska, Nicholas C. Turner, Christos Vaklavas, Christopher J. Morrow, Manuel Ruíz-Borrego, Irene Moreno, Justin P.O. Lindemann, Jason Incorvati, Eva Ciruelos, Richard D. Baird, Jincheng Yang

October 15, 2025article en

Supplementary Figure S3 from Camizestrant in Combination with Three Globally Approved CDK4/6 Inhibitors in Women with ER+, HER2− Advanced Breast Cancer: Results from SERENA-1

Authors

Publication Details

Supplementary Figure S3 from Camizestrant in Combination with Three Globally Approved CDK4/6 Inhibitors in Women with ER+, HER2− Advanced Breast Cancer: Results from SERENA-1

Supplementary Figure S3 from Camizestrant in Combination with Three Globally Approved CDK4/6 Inhibitors in Women with ER+, HER2− Advanced Breast Cancer: Results from SERENA-1

Abstract

Ask Laika to Summarize, Analyze, and Connect papers live on the map.